Search Results 2331-2340 of 16195 for Epilepsy (Partial Onset)
This phase II trial studies how well isatuximab works in treating patients with primary amyloidosis that has come back or does not respond to treatment.
The early research in animal models could advance an already approved Food ... (VIDEO) When seizures don't stop: The battle against drug-resistant epilepsy.
There are also less common very early (phase 0) and later (phase 4) phases. ... duration of the trial, or is not in the best interest of the subject to ...
A second part of this study will involve using a Fitbit consumer wearable device to obtain sleep and activity data on participants for 2 months in duration. .
International normalized ratio (INR)/prothrombin time and either partial thromboplastin time (PTT) or activated PTT ≤ 1.5 × ULN, except for subjects ...
Women of childbearing potential shall either be surgically sterile or must agree not to become pregnant for the duration of the study. Subjects of ...
Neuromyelitis Optica: New Therapies Offer Hope · Precise and Personalized Guidance for Epilepsy's Complex Decisions · Comprehensive Mapping of Cognitive Functions ...
This rare, slow-growing soft tissue cancer tends to occur in teenagers and young adults. It often starts in a hand, wrist, arm or leg.
... seizures. PLoS One. 2011 Jan 24; 6 (1):e16331. View PubMed; Schneekloth TD, Biernacka JM, Hall-Flavin DK, Karpyak VM, Frye MA, Loukianova LL, Stevens SR ...
The purpose of this study is to evaluate the effectiveness and safety of tazemetostat in combination with R2 in subjects with Relapsed/Refractory Follicular ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
The deadline to have twice the impact to advance healthcare research is May 15.